Literature DB >> 9291677

Novel putative protective antigens of Plasmodium falciparum.

S Sharma1, M K Bhattacharyya.   

Abstract

In an attempt to identify putative host-protective antigens of the human malarial parasite P. falciparum, a differential immunoscreen of a cDNA expression library of the parasite was performed using malaria immune and patient sera. Eight expression clones were identified which showed no reactivity with acute patient sera but reacted extensively with malaria immune sera. Southern Blot analysis of five of these genes showed that these were coded by unique single genes, and sequence of the cDNA inserts showed that these were as yet unidentified genes of P. falciparum. The clone which was reactive to the largest number of immune sera, has been shown to be the ribosomal phosphoprotein, P0, of P. falciparum. The presence of multiple transcripts and a differential expression of the transcripts of P0 in different erythrocytic substages of the parasite was observed. An extensive characterisation using antibodies to the P0 protein has been performed. The results show that in addition to its role in the ribosomal assembly, the P0 protein is also localized on the parasite surface, and plays an important role in the red blood cell invasion. Most of the other differential cDNA clones were found to be rare transcripts, and the expression domains were not very immunogenic. PCR analysis of three of these genes demonstrated that these are conserved throughout the Plasmodium species. These protein domains, therefore, constitute potential protective target epitopes of the malarial parasite.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9291677

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  1 in total

1.  Molecular characterization of a Brugia malayi transglutaminase.

Authors:  Eswaran Devarajan; Pankaj Kumar Mishra; Shiva Thirugnanam; Kapil Mehta; Ramaswamy Chandrashekar; Kaliraj Perumal
Journal:  Parasitol Res       Date:  2004-05-01       Impact factor: 2.289

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.